Kazuaki Shinoda
Kazuaki Shinoda publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Metabolism, Diabetes, and Cancer.
- World rank
- #6,442,502 of 7,710,434 ranked researchers
- Rank in Japan
- #257,795 of 383,136
- Works
- 19
- Citations
- 240
- Citations per work
- 12.6
What does Kazuaki Shinoda research?
Kazuaki Shinoda's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1476.0%
- Medicine1476.0%
- Life Sciences213.0%
- Everything else211.0%
- 1Endocrinology, Diabetes and Metabolism57% of their works
- 2Molecular Biology11% of their works
- 3Surgery11% of their works
- 4Pharmacology6% of their works
- 5Immunology2% of their works
- 6Emergency Medicine2% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Pharmacology and Obesity Treatment
- Pancreatic function and diabetes
- Bariatric Surgery and Outcomes
Which keywords describe Kazuaki Shinoda's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Type 2 Diabetes, Cardiovascular Disease, Cardiovascular Outcomes, Glucose Control and Obesity.
- Pancreatic Islets
- Bariatric Surgery
- Hyperglycemia
- Anti-Obesity Drugs
- Metformin
- Insulin Resistance
- AMP-Activated Protein Kinase
- Hypoglycemia
- Obesity
- Cardiovascular Outcomes
- Type 2 Diabetes
- Insulin Therapy
- Glycemic Control
- Diabetes
- Cardiovascular Disease
- Glucose Control
- Continuous Glucose Monitoring
- Lifestyle Intervention
- Diabetes Mellitus
- Metabolic Syndrome
- Weight Loss
- Critical Care
- Pharmacotherapy
- Metabolic Surgery
- ß-Cell Dysfunction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Glycemic Control263 topics
- Insulin Therapy263 topics
- Diabetes163 topics
- Type 2 Diabetes162 topics
- Cardiovascular Disease142 topics
- Cardiovascular Outcomes141 topic
- Glucose Control141 topic
- Obesity103 topics
- Continuous Glucose Monitoring91 topic
- Hypoglycemia91 topic
- Lifestyle Intervention72 topics
- AMP-Activated Protein Kinase51 topic
- Diabetes Mellitus52 topics
- Insulin Resistance51 topic
- Metabolic Syndrome51 topic
- Metformin51 topic
- Weight Loss52 topics
- Anti-Obesity Drugs31 topic
- Critical Care31 topic
- Hyperglycemia31 topic
- Pharmacotherapy31 topic
- Bariatric Surgery21 topic
- Metabolic Surgery21 topic
- Pancreatic Islets21 topic
- ß-Cell Dysfunction21 topic
Where does Kazuaki Shinoda work?
Kazuaki Shinoda's main affiliation in the publication record is Yokohama City University, Japan.
How many publications and citations does Kazuaki Shinoda have?
OpenAlex counts 19 works and 240 citations for Kazuaki Shinoda, an h-index of 8, ranking #6,442,502 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kazuaki Shinoda. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.